Insider · CIK 0002039341
Carter Robert Ross
cfoofficer
Files at STLN (Oncology Institute, Inc.). First filing Mar 28, 2025, latest Mar 28, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$9,434 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 43Moderate | buy 5 | STLN Oncology Institute, Inc. | $9,434 | 9,056 | +30% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +9,056 | $1.04 | $9,434 | 39,407 | Mar 28, 2025 |
| Mar 26, 2025 | STLN Oncology Institute, Inc. | POpen-market purchase Common Warrantderivative | +4,528 | $0.13 | $566 | 4,528 | Mar 28, 2025 |
| Mar 19, 2025 | STLN Oncology Institute, Inc. | DDisposition to issuer Class A Common Stock | -1,150 | $0.89 | $1,022 | 30,351 | Mar 20, 2025 |
| Jan 6, 2025 | STLN Oncology Institute, Inc. | DDisposition to issuer Class A Common Stock | -258 | $0.34 | $86 | 31,501 | Jan 7, 2025 |
| Nov 20, 2024 | STLN Oncology Institute, Inc. | DDisposition to issuer Class A Common Stock | -235 | $0.14 | $32 | 31,759 | Nov 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.